AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 296: F1088-F1099, 2009. First published February 18, 2009; doi:10.1152/ajprenal.90746.2008
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/5/F1088    most recent
90746.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer-Schwesinger, C.
Right arrow Articles by Meyer, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer-Schwesinger, C.
Right arrow Articles by Meyer, T. N.

Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-{kappa}B p65 signaling

Catherine Meyer-Schwesinger, Silke Dehde, Claudia von Ruffer, Stefan Gatzemeier, Philipp Klug, Ulrich O. Wenzel, Rolf A. K. Stahl, Friedrich Thaiss,* and Tobias N. Meyer*

Department of Internal Medicine, University Hospital Hamburg, Hamburg, Germany

Submitted 15 December 2008 ; accepted in final form 13 February 2009

Rho kinase signaling regulates inflammatory cell migration and chemokine production. We therefore investigated the mechanisms of Rho-kinase-dependent inflammation in lipopolysaccharide (LPS)-induced renal failure. C57/BL6 mice received intraperitoneal LPS with or without daily treatment with specific Rho kinase inhibitors (Y-27632 or HA-1077; 5 mg/kg). Rho kinase inhibitors were applied in a preventive (12 or 1 h before LPS) or a therapeutic (6 h after LPS) scheme. Both protected renal function and decreased tubular injury in LPS-treated mice. Enhanced Rho kinase activity was inhibited by HA-1077 in capillary endothelial cells, inflammatory cells, and tubuli by analysis of Rho kinase substrate phosphorylation. Early neutrophil influx was reduced by HA-1077 without reduction of the proinflammatory cytokine TNF{alpha}. In contrast, HA-1077 decreased the influx of monocytes/macrophages coinciding with reduced expression of the NF-{kappa}B-regulated chemokines CCL5 and CCL2. We therefore examined NF-{kappa}B signal transduction and found that NF-{kappa}B p65 phosphorylation and nuclear translocation were reduced by Rho kinase inhibition. I{kappa}B{alpha} degradation was not altered during the first 6 h but was reduced by HA-1077 at later time points. NF-{kappa}B p50-deficient mice were similarly protected from renal injury by Rho kinase inhibition further supporting the prominent role for p65 in Rho kinase inhibition. Together, these data suggest that Rho kinase inhibition by preventive or therapeutic treatment effectively reduced endotoxic kidney injury in part by attenuation of NF-{kappa}B p65 activation.

lipopolysaccharide; nephritis; nuclear factor-{kappa}B



Address for reprint requests and other correspondence: T. N. Meyer, Dept. of Internal Medicine, Div. of Nephrology, Univ. Hospital Hamburg-Eppendorf, Campus Forschung, Rm. 03.004, Martinistr. 52, 20246 Hamburg, Germany (e-mail: t.meyer{at}uke.uni-hamburg.de)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
U. Panzer, O. M. Steinmetz, J.-E. Turner, C. Meyer-Schwesinger, C. von Ruffer, T. N. Meyer, G. Zahner, C. Gomez-Guerrero, R. M. Schmid, U. Helmchen, et al.
Resolution of renal inflammation: a new role for NF-{kappa}B1 (p50) in inflammatory kidney diseases
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F429 - F439.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.